1. Home
  2. AMPH vs SGP Comparison

AMPH vs SGP Comparison

Compare AMPH & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

N/A

Current Price

$28.25

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Logo SpyGlass Pharma Inc. Common Stock

SGP

SpyGlass Pharma Inc. Common Stock

N/A

Current Price

$30.62

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AMPH
SGP
Founded
1996
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2005
2026

Fundamental Metrics

Financial Performance
Metric
AMPH
SGP
Price
$28.25
$30.62
Analyst Decision
Hold
Strong Buy
Analyst Count
7
6
Target Price
$24.50
★ $46.67
AVG Volume (30 Days)
★ 433.1K
105.7K
Earning Date
11-05-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 1.67
N/A
Revenue
★ $719,887,000.00
N/A
Revenue This Year
$3.81
N/A
Revenue Next Year
$4.91
N/A
P/E Ratio
$16.84
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$16.65
$17.06
52 Week High
$31.00
$39.92

Technical Indicators

Market Signals
Indicator
AMPH
SGP
Relative Strength Index (RSI) 54.84 48.47
Support Level $24.37 $23.55
Resistance Level $29.23 $39.92
Average True Range (ATR) 1.26 2.66
MACD -0.08 -0.71
Stochastic Oscillator 36.22 24.29

Price Performance

Historical Comparison
AMPH
SGP

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

About SGP SpyGlass Pharma Inc. Common Stock

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

Share on Social Networks: